Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Illinois Bill Aims to Limit Custom Compound Reimbursements

If passed, the bill would limit reimbursements to a one-time, seven-day supply if no commercial equivalent exists.
Read More →
January 20, 2025

Psychedelic Bills in Colorado, New Hampshire, New York, Virginia, and Washington

Five different states are proposing legislation for psychedelic therapy or legalized use for the treatment of PTSD and other mental illnesses.
Read More →
January 20, 2025

Illinois Proposes PTSD Presumptions for First Responders

One bill would create the presumption, while another would shift the burden of proof to the employing entity and any party attacking the presumption.
Read More →
January 20, 2025

Montana May Recognize Physical Therapists as Treating Physicians

If Senate Bill 109 is passed, physical therapists would have the same rights as treating physicians, letting them deliver and coordinate care.
Read More →
January 20, 2025

California Report Finds Dermatological Agents Rank Highest in Drug Spend

According to claim data from the CWCI, in 2024 dermatological agents made up 12.6% of prescriptions and 18.9% of drug spend.
Read More →
January 20, 2025

Maryland Proposes Pharmacy Fee Schedule with Actual Acquisition Cost

If enacted, this fee schedule would replace the current usual and customary charges, going into effect October 1, 2025.
Read More →
January 20, 2025

WCRI Publishes New Report on Heat-Related Illnesses

Approximately 210 out of every 100,000 claims were for heat-related illness, but the rate increases for inexperienced workers and outdoor workers.
Read More →
January 13, 2025

Virginia Proposes Longer and Expanded Benefits for PTSD Among First Responders

Three separate bills were introduced, two which increase maximum duration of benefits, while one would expand benefits to dispatchers.
Read More →
January 13, 2025

New York Introduces Psilocybin Therapy Bill

Senate Bill 495 seeks to legalize medical psilocybin under strict conditions with state-regulated training, research, reporting, and more.
Read More →
January 13, 2025
1 … 27 28 29 30 31 … 41

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

New York Prepares to Launch New Claim Portal

Stakeholders will soon experience a streamlined digital process for managing claims.
Read More

FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.
Read More

Side Effects: COVID-19-Related Healthcare and Pharmacy Trends Impacting Workers’ Comp

The pandemic has disrupted access to care, but the industry has implemented reactive measures
Read More

Returning to Work in the COVID-19 Era

Considerations for infection prevention, unique population factors, and more
Read More

Moving Forward: How Should Opioid Guidance Continue to Evolve?

Opioid use has decreased, prompting calls for reform, but COVID-19 complicates opioid use
Read More
1 … 27 28 29 30 31 … 47
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle